1. Home
  2. CRGX vs AMPS Comparison

CRGX vs AMPS Comparison

Compare CRGX & AMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • AMPS
  • Stock Information
  • Founded
  • CRGX 2021
  • AMPS 2009
  • Country
  • CRGX United States
  • AMPS United States
  • Employees
  • CRGX N/A
  • AMPS N/A
  • Industry
  • CRGX
  • AMPS Electric Utilities: Central
  • Sector
  • CRGX
  • AMPS Utilities
  • Exchange
  • CRGX Nasdaq
  • AMPS Nasdaq
  • Market Cap
  • CRGX 621.4M
  • AMPS 608.0M
  • IPO Year
  • CRGX 2023
  • AMPS N/A
  • Fundamental
  • Price
  • CRGX $12.68
  • AMPS $3.48
  • Analyst Decision
  • CRGX Strong Buy
  • AMPS Strong Buy
  • Analyst Count
  • CRGX 6
  • AMPS 9
  • Target Price
  • CRGX $31.80
  • AMPS $5.38
  • AVG Volume (30 Days)
  • CRGX 279.0K
  • AMPS 1.4M
  • Earning Date
  • CRGX 11-12-2024
  • AMPS 03-13-2025
  • Dividend Yield
  • CRGX N/A
  • AMPS N/A
  • EPS Growth
  • CRGX N/A
  • AMPS N/A
  • EPS
  • CRGX N/A
  • AMPS 0.22
  • Revenue
  • CRGX N/A
  • AMPS $185,992,000.00
  • Revenue This Year
  • CRGX N/A
  • AMPS $30.56
  • Revenue Next Year
  • CRGX N/A
  • AMPS $17.93
  • P/E Ratio
  • CRGX N/A
  • AMPS $16.30
  • Revenue Growth
  • CRGX N/A
  • AMPS 25.90
  • 52 Week Low
  • CRGX $10.91
  • AMPS $2.71
  • 52 Week High
  • CRGX $33.92
  • AMPS $7.28
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 42.38
  • AMPS 33.34
  • Support Level
  • CRGX $10.91
  • AMPS $3.82
  • Resistance Level
  • CRGX $13.10
  • AMPS $4.24
  • Average True Range (ATR)
  • CRGX 1.11
  • AMPS 0.25
  • MACD
  • CRGX 0.02
  • AMPS -0.09
  • Stochastic Oscillator
  • CRGX 38.21
  • AMPS 0.00

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About AMPS Altus Power Inc.

Altus Power Inc is a developer, owner, and operator of large-scale photovoltaic and energy storage systems across the United States. The company serve commercial, industrial, public sector, and community solar customers. Its mission is to drive the clean energy transition by developing and operating solar generation and energy storage facilities. It owns a diverse portfolio of solar PV systems and has long-term agreements with enterprise entities and residential customers. Their primary product offerings include leases and revenue contracts for solar power generation, alongside electric vehicle charging and energy storage solutions. Revenue streams include power purchase agreements, net metering credit agreements, and SREC revenue.

Share on Social Networks: